Gastrolav en es it fr

Gastrolav Brand names, Gastrolav Analogs

Gastrolav Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Gastrolav Chemical_Formula


Gastrolav RX_link

Gastrolav fda sheet

Gastrolav FDA

Gastrolav msds (material safety sheet)

Gastrolav MSDS

Gastrolav Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Gastrolav Molecular Weight

314.405 g/mol

Gastrolav Melting Point

69-70 oC

Gastrolav H2O Solubility

24.7 mg/mL

Gastrolav State


Gastrolav LogP


Gastrolav Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Gastrolav Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Gastrolav Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Gastrolav Absorption

Approximately 50% bioavailability orally.

Gastrolav side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Gastrolav Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Gastrolav Organisms Affected

Humans and other mammals